DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Albrecht S, Schochter F, Melcher C et al.
DETECT III – a multicenter, randomized, phase III trial to assess efficacy of lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells (CTCs).

Oncol Res Treat 2014;
37: 29-29

Download Bibliographical Data

Search in: